Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 7
1964 4
1965 4
1966 1
1967 3
1968 4
1969 2
1970 3
1971 1
1972 3
1973 3
1974 6
1975 9
1976 4
1977 6
1978 3
1979 6
1980 8
1981 5
1982 2
1983 13
1984 3
1985 6
1986 16
1987 9
1988 9
1989 9
1990 10
1991 12
1992 10
1993 8
1994 10
1995 17
1996 9
1997 9
1998 13
1999 23
2000 34
2001 27
2002 30
2003 36
2004 21
2005 24
2006 21
2007 18
2008 14
2009 23
2010 21
2011 17
2012 21
2013 14
2014 16
2015 18
2016 22
2017 19
2018 18
2019 27
2020 29
2021 36
2022 28
2023 19

Text availability

Article attribute

Article type

Publication date

Search Results

770 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study.
Tamaki S, Yamada T, Watanabe T, Morita T, Furukawa Y, Kawasaki M, Kikuchi A, Kawai T, Seo M, Abe M, Nakamura J, Yamamoto K, Kayama K, Kawahira M, Tanabe K, Fujikawa K, Hata M, Fujita Y, Umayahara Y, Taniuchi S, Sanada S, Shintani A, Fukunami M. Tamaki S, et al. Among authors: fujikawa k. Circ Heart Fail. 2021 Mar;14(3):e007048. doi: 10.1161/CIRCHEARTFAILURE.120.007048. Epub 2021 Mar 5. Circ Heart Fail. 2021. PMID: 33663235 Clinical Trial.
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).
Yamazaki K, Nagase M, Tamagawa H, Ueda S, Tamura T, Murata K, Eguchi Nakajima T, Baba E, Tsuda M, Moriwaki T, Esaki T, Tsuji Y, Muro K, Taira K, Denda T, Funai S, Shinozaki K, Yamashita H, Sugimoto N, Okuno T, Nishina T, Umeki M, Kurimoto T, Takayama T, Tsuji A, Yoshida M, Hosokawa A, Shibata Y, Suyama K, Okabe M, Suzuki K, Seki N, Kawakami K, Sato M, Fujikawa K, Hirashima T, Shimura T, Taku K, Otsuji T, Tamura F, Shinozaki E, Nakashima K, Hara H, Tsushima T, Ando M, Morita S, Boku N, Hyodo I. Yamazaki K, et al. Among authors: fujikawa k. Ann Oncol. 2016 Aug;27(8):1539-46. doi: 10.1093/annonc/mdw206. Epub 2016 May 13. Ann Oncol. 2016. PMID: 27177863 Free article. Clinical Trial.
Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis.
Okuda K, Nakahara K, Ito A, Iijima Y, Nomura R, Kumar A, Fujikawa K, Adachi K, Shimada Y, Fujio S, Yamamoto R, Takasugi N, Onuma K, Osaki M, Okada F, Ukegawa T, Takeuchi Y, Yasui N, Yamashita A, Marusawa H, Matsushita Y, Katagiri T, Shibata T, Uchida K, Niu SY, Lang NB, Nakamura T, Zhang KYJ, Lipton SA, Uehara T. Okuda K, et al. Among authors: fujikawa k. Nat Commun. 2023 Feb 4;14(1):621. doi: 10.1038/s41467-023-36232-6. Nat Commun. 2023. PMID: 36739439 Free PMC article.
Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis.
Iwamoto N, Sato S, Kurushima S, Michitsuji T, Nishihata S, Okamoto M, Tsuji Y, Endo Y, Shimizu T, Sumiyoshi R, Suzuki T, Okada A, Koga T, Kawashiri SY, Fujikawa K, Igawa T, Aramaki T, Ichinose K, Tamai M, Nakamura H, Mizokami A, Origuchi T, Ueki Y, Eguchi K, Kawakami A. Iwamoto N, et al. Among authors: fujikawa k. Arthritis Res Ther. 2021 Jul 23;23(1):197. doi: 10.1186/s13075-021-02582-z. Arthritis Res Ther. 2021. PMID: 34301311 Free PMC article.
Flavonoids from Sedum japonicum subsp. oryzifolium (Crassulaceae).
Mizuno T, Uchiyama N, Tanaka S, Nakane T, Devkota HP, Fujikawa K, Kawahara N, Iwashina T. Mizuno T, et al. Among authors: fujikawa k. Molecules. 2022 Nov 7;27(21):7632. doi: 10.3390/molecules27217632. Molecules. 2022. PMID: 36364459 Free PMC article.
HPLC-assisted automated oligosaccharide synthesis.
Ganesh NV, Fujikawa K, Tan YH, Stine KJ, Demchenko AV. Ganesh NV, et al. Among authors: fujikawa k. Org Lett. 2012 Jun 15;14(12):3036-9. doi: 10.1021/ol301105y. Epub 2012 May 30. Org Lett. 2012. PMID: 22646669 Free PMC article.
Very Late-Onset Dabigatran-Induced Esophageal Injury.
Fujikawa K, Takasugi N, Goto T, Minatoguchi S. Fujikawa K, et al. Can J Cardiol. 2017 Apr;33(4):554.e15-554.e16. doi: 10.1016/j.cjca.2016.12.017. Epub 2016 Dec 29. Can J Cardiol. 2017. PMID: 28343609
Cytoskeletal remodeling in lymphocyte activation.
Miletic AV, Swat M, Fujikawa K, Swat W. Miletic AV, et al. Among authors: fujikawa k. Curr Opin Immunol. 2003 Jun;15(3):261-8. doi: 10.1016/s0952-7915(03)00054-2. Curr Opin Immunol. 2003. PMID: 12787750 Review.
770 results